Ardelyx

ARDX · NASDAQ

$3.21+$0.12 (+3.88%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $3.09

Latest news

Press releaseOct 20, 7:30 AM ETGlobe Newswire
Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026
Press releaseOct 19, 2:15 PM ETGlobe Newswire
Robbins LLP Urges ARDX Stockholders to Contact the Firm for Information About the Securities Class Action Against Ardelyx, Inc.
Press releaseOct 19, 4:50 AM ETNewsfile
Kaplan Fox Reminds Investors of a Securities Class Action Against Ardelyx, Inc. (ARDX) - Deadline is November 16, 2026
Press releaseOct 15, 7:45 PM ETNewsfile
Kaplan Fox Encourages Ardelyx, Inc. (ARDX) Investors to Contact the Firm Before the Deadline on November 16, 2026 for a Leadership Role
Press releaseOct 15, 10:17 AM ETPRNewswire
ARDX Shareholder Alert: Ardelyx, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt
Press releaseOct 15, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines - ARDX
Press releaseOct 14, 6:02 PM ETPRNewswire
ARDX Stockholders Have Rights - If You Lost Money Investing in Ardelyx, Inc. Contact Robbins LLP for Information About Recovering Your Losses
Press releaseOct 14, 10:18 AM ETPRNewswire
ARDX DEADLINE: Levi & Korsinsky Reminds Ardelyx, Inc. Investors of Upcoming Securities Class Action Deadline
Press releaseOct 13, 10:14 PM ETPRNewswire
Ardelyx, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ARDX
Press releaseOct 13, 7:10 PM ETNewsfile
Kaplan Fox Advises Ardelyx, Inc. (ARDX) Investors to Act Before the Lead Plaintiff Deadline on November 16, 2026
Press releaseOct 13, 5:27 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines – ARDX
Press releaseOct 13, 2:44 PM ETGlobe Newswire
ARDX Shareholder Alert: Ardelyx, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt
Press releaseOct 12, 8:01 AM ETGlobe Newswire
Ardelyx Presents Real-World Data at ACG 2026 Showing Reduced Healthcare Resource Utilization Following IBSRELA® Initiation in Adults with IBS-C
Press releaseOct 9, 8:50 AM ETNewsfile
Kaplan Fox Announces a Securities Class Action Filed Against Ardelyx, Inc. (ARDX) - Lead Plaintiff Deadline is November 16, 2026
Press releaseOct 8, 3:18 PM ETPRNewswire
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law
Press releaseOct 8, 10:11 AM ETPRNewswire
SueWallSt Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026 - ARDX
Press releaseOct 7, 1:10 PM ETGlobe Newswire
ARDX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Ardelyx (NASDAQ: ARDX) Investors of Securities Class Action Lawsuit Deadline on November 16, 2026
Press releaseOct 7, 11:05 AM ETNewsfile
Kaplan Fox Alerts Investors of Ardelyx, Inc. (ARDX) with Significant Losses to a Securities Class Action Deadline on November 16, 2026
Press releaseOct 6, 5:57 PM ETNewsfile
Ardelyx, Inc. (ARDX) Investor News: Rosen Law Firm Reminds Ardelyx, Inc. Investors of Securities Class Action Deadline
Press releaseOct 6, 12:12 PM ETGlobe Newswire
ARDX Shareholder Alert: November 16, 2026 Lead Plaintiff Deadline in Ardelyx, Inc. Securities Class Action - Contact SueWallSt
Press releaseOct 5, 11:00 AM ETNewsfile
Kaplan Fox Alerts Ardelyx, Inc. (ARDX) Investors Who Suffered Losses to a Securities Class Action - Deadline is November 16, 2026
Press releaseOct 5, 8:57 AM ETGlobe Newswire
Important Notice to Long-Term Shareholders of Anavex Life Sciences Corp. (NASDAQ: AVXL); Ardelyx, Inc. (NASDAQ: ARDX); Aardvark Therapeutics, Inc. (NASDAQ: AARD); and GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI): Grabar Law Office is Investigating Claims on Your Behalf
Press releaseOct 5, 8:01 AM ETGlobe Newswire
Ardelyx to Present New Data on Hyperphosphatemia Management at ASN Kidney Week 2026
Press releaseOct 5, 7:05 AM ETBusiness Wire
Robbins LLP Urges ARDX Stockholders Who Lost Money Investing in Ardelyx, Inc. to Contact the Firm for Information About Leading the Class Action
Press releaseOct 1, 9:05 PM ETNewsfile
Kaplan Fox Reminds Ardelyx, Inc. (ARDX) Investors with Significant Losses to Seek a Leadership Role Before Deadline on November 16, 2026
Press releaseOct 1, 10:11 AM ETPRNewswire
ARDX Deadline Alert: SueWallSt Reminds Ardelyx, Inc. (ARDX) Investors of Securities Class Action Deadline on November 16, 2026
Press releaseSep 30, 5:06 PM ETNewsfile
Robbins LLP is Investigating Allegations that Ardelyx, Inc. Misled Investors Regarding the True State of the Company's Commercial Performance and Growth Prospects for its Two Core Drug Products
Press releaseSep 30, 12:51 PM ETPRNewswire
ARDX UPCOMING DEADLINE: Levi & Korsinsky Alerts Ardelyx, Inc. Stockholders of Securities Class Action - Contact the Firm
Press releaseSep 29, 8:30 PM ETNewsfile
Kaplan Fox Encourages Ardelyx, Inc. (ARDX) Investors with Significant Losses to Contact the Firm Before November 16, 2026
NewsSep 18, 6:13 AM ET
Ardelyx Q2 2026 Earnings Call Transcript
Press releaseAug 18, 10:13 AM ETGlobe Newswire
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Ardelyx (ARDX)
Press releaseAug 14, 10:07 AM ETPRNewswire
ARDX SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Ardelyx
NewsAug 7, 8:05 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsAug 7, 8:02 AM ETAvi Kapoor
Trade Desk Posts Downbeat Q2 Results, Joins Sezzle, Resmed, Ouster And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
NewsAug 7, 4:33 AM ETAvi Kapoor
Why Atlassian Shares Are Trading Higher By More Than 30%; Here Are 20 Stocks Moving Premarket
NewsAug 6, 5:06 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
Press releaseAug 6, 4:05 PM ETGlobe Newswire
Ardelyx Reports Second Quarter 2026 Financial Results and Provides Business Update
Press releaseApr 30, 4:01 PM ETGlobe Newswire
Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update
NewsApr 30, 7:11 AM ET
Earnings Scheduled For April 30, 2026
Press releaseApr 20, 8:00 AM ETGlobe Newswire
Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer
Press releaseApr 1, 8:01 AM ETGlobe Newswire
Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx
Press releaseFeb 24, 8:00 AM ETGlobe Newswire
Ardelyx and the LPGA Announce Multi-Year Partnership to Break Stigma Around Digestive Health Issues Impacting Millions
NewsFeb 20, 9:00 AM ET
Breaking Down Ardelyx: 7 Analysts Share Their Views
NewsFeb 19, 4:06 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
Press releaseFeb 19, 4:01 PM ETGlobe Newswire
Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
NewsFeb 18, 2:01 PM ET
Insights Ahead: Ardelyx's Quarterly Earnings
NewsOct 31, 11:37 AM ETAvi Kapoor
Cloudflare Posts Upbeat Q3 Results, Joins Amazon, Roku, Coinbase, Atlassian And Other Big Stocks Moving Higher On Friday

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026

Robbins LLP Urges ARDX Stockholders to Contact the Firm for Information About the Securities Class Action Against Ardelyx, Inc.

Kaplan Fox Reminds Investors of a Securities Class Action Against Ardelyx, Inc. (ARDX) - Deadline is November 16, 2026

Kaplan Fox Encourages Ardelyx, Inc. (ARDX) Investors to Contact the Firm Before the Deadline on November 16, 2026 for a Leadership Role

ARDX Shareholder Alert: Ardelyx, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines - ARDX

ARDX Stockholders Have Rights - If You Lost Money Investing in Ardelyx, Inc. Contact Robbins LLP for Information About Recovering Your Losses

ARDX DEADLINE: Levi & Korsinsky Reminds Ardelyx, Inc. Investors of Upcoming Securities Class Action Deadline

Ardelyx, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ARDX

Kaplan Fox Advises Ardelyx, Inc. (ARDX) Investors to Act Before the Lead Plaintiff Deadline on November 16, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines – ARDX

ARDX Shareholder Alert: Ardelyx, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt

Ardelyx Presents Real-World Data at ACG 2026 Showing Reduced Healthcare Resource Utilization Following IBSRELA® Initiation in Adults with IBS-C

Kaplan Fox Announces a Securities Class Action Filed Against Ardelyx, Inc. (ARDX) - Lead Plaintiff Deadline is November 16, 2026

ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law

SueWallSt Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026 - ARDX

ARDX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Ardelyx (NASDAQ: ARDX) Investors of Securities Class Action Lawsuit Deadline on November 16, 2026

Kaplan Fox Alerts Investors of Ardelyx, Inc. (ARDX) with Significant Losses to a Securities Class Action Deadline on November 16, 2026

Ardelyx, Inc. (ARDX) Investor News: Rosen Law Firm Reminds Ardelyx, Inc. Investors of Securities Class Action Deadline

ARDX Shareholder Alert: November 16, 2026 Lead Plaintiff Deadline in Ardelyx, Inc. Securities Class Action - Contact SueWallSt

Kaplan Fox Alerts Ardelyx, Inc. (ARDX) Investors Who Suffered Losses to a Securities Class Action - Deadline is November 16, 2026

Important Notice to Long-Term Shareholders of Anavex Life Sciences Corp. (NASDAQ: AVXL); Ardelyx, Inc. (NASDAQ: ARDX); Aardvark Therapeutics, Inc. (NASDAQ: AARD); and GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI): Grabar Law Office is Investigating Claims on Your Behalf

Ardelyx to Present New Data on Hyperphosphatemia Management at ASN Kidney Week 2026

Robbins LLP Urges ARDX Stockholders Who Lost Money Investing in Ardelyx, Inc. to Contact the Firm for Information About Leading the Class Action

Kaplan Fox Reminds Ardelyx, Inc. (ARDX) Investors with Significant Losses to Seek a Leadership Role Before Deadline on November 16, 2026

ARDX Deadline Alert: SueWallSt Reminds Ardelyx, Inc. (ARDX) Investors of Securities Class Action Deadline on November 16, 2026

Robbins LLP is Investigating Allegations that Ardelyx, Inc. Misled Investors Regarding the True State of the Company's Commercial Performance and Growth Prospects for its Two Core Drug Products

ARDX UPCOMING DEADLINE: Levi & Korsinsky Alerts Ardelyx, Inc. Stockholders of Securities Class Action - Contact the Firm

Kaplan Fox Encourages Ardelyx, Inc. (ARDX) Investors with Significant Losses to Contact the Firm Before November 16, 2026

Ardelyx Q2 2026 Earnings Call Transcript

Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Ardelyx (ARDX)

ARDX SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Ardelyx

12 Health Care Stocks Moving In Friday's Pre-Market Session

Trade Desk Posts Downbeat Q2 Results, Joins Sezzle, Resmed, Ouster And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

Why Atlassian Shares Are Trading Higher By More Than 30%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Thursday's After-Market Session

Ardelyx Reports Second Quarter 2026 Financial Results and Provides Business Update

Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update

Earnings Scheduled For April 30, 2026

Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer

Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx

Ardelyx and the LPGA Announce Multi-Year Partnership to Break Stigma Around Digestive Health Issues Impacting Millions

Breaking Down Ardelyx: 7 Analysts Share Their Views

12 Health Care Stocks Moving In Thursday's After-Market Session

Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Insights Ahead: Ardelyx's Quarterly Earnings

Cloudflare Posts Upbeat Q3 Results, Joins Amazon, Roku, Coinbase, Atlassian And Other Big Stocks Moving Higher On Friday